Page last updated: 2024-10-28

fasudil and Chemical and Drug Induced Liver Injury, Chronic

fasudil has been researched along with Chemical and Drug Induced Liver Injury, Chronic in 1 studies

fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.

Chemical and Drug Induced Liver Injury, Chronic: Liver disease lasting six months or more, caused by an adverse effect of a drug or chemical. The adverse effect may be caused by drugs, drug metabolites, chemicals from the environment, or an idiosyncratic response.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Namba, N1
Kuwahara, T1
Kondo, Y1
Fukusaki, K1
Miyata, K1
Oike, Y1
Irie, T1
Ishitsuka, Y1

Other Studies

1 other study available for fasudil and Chemical and Drug Induced Liver Injury, Chronic

ArticleYear
Fasudil inhibits the expression of C/EBP homologous protein to protect against liver injury in acetaminophen-overdosed mice.
    Biochemical and biophysical research communications, 2023, Dec-17, Volume: 686

    Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Inju

2023